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Hyperlipemia,  often of striking  degree,  can  be  induced  readily  in  experi- 
mental animals by the  intravenous injection of certain surface-active agents 
(1),  though  the  precise  mechanism whereby  the  increase  in  blood lipides  is 
brought about remains obscure. In order to learn more about the pathogenesis 
of this experimental hyperlipemia, and perhaps also about that of other nat- 
urally occurring hyperlipemias,  a  study was undertaken of the effects of the 
surface-active  agent  triton  WR  1339  on  the  intermediary  metabolism  of 
lipides. The experiments to be reported in this paper were done to determine, 
if possible,  whether the increase in circulating blood lipides  that follows par- 
enteral  injection of triton WR  1339  resulted  from a  redistribution  of lipides 
within the body, from an increase in their synthesis, or from some interference 
with their degradation and excretion.  1 
Materials and Methods 
The aim of the experiments now to be described was to determine whether 
there was a  change in  the  total body cholesterol of animals rendered hyper- 
lipemic  by means  of  the  parenteral  administration  of  triton  WR  1339.  Ac- 
cordingly, groups of mice .were given single  or repeated  intravenous or sub- 
cutaneous injections of triton WR 1339; after ascertaining  that  this resulted 
in  hyperlipemia,  the  total  amount of cholesterol  in  the  body was measured 
and compared with that of suitable  control animals. 
Animals and Dia.--The animals used in these studies were adult white male Swiss mice 
from the same stock and obtained from a single dealer. They were maintained on a diet of 
Rockland rabbit pellets which is low in fat and which has been found previously in this 
laboratory to be free of cholesterol. 
* This work was supported by grants from the National Heart Institute of the United 
States Public Health Service and The New York Heart Association. 
:~ Fellow of The New York Heart Association. 
x  A preliminary report of these studies appeared in Fed. Proc., 1954, 13, 432. 
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Surface-Active Agent.--Triton A-20,  * which is a  25 per cent solution d  triton WR 1339, 
was the surface-active agent employed. For purposes of injection it was diluted with equal 
parts  of  0.9  per cent sodium chloride  to  make a final  concentration  of  12.5  per  cent triton,  and 
given either  intravenously or subcutaneously in a dose of 0.2 cc. per animal. The animals 
appeared in good health and there was no appreciable change in weight following  single  or 
repeated parenteral  injections  of triton,  a 
LipCde  Determin~ions.--Blood  for lipide  determinations was obtained from the intact, 
unanesthetizcd animal by severing the jugular vein;  0.5 to 0.8 cc. was obtained in most 
instances.  Blood from 3 to 5 animais was pooled in the case of the uninjected normal mice; 
determinations were done on individual  blood specimens in the case of the injected,  hyper- 
lipemic  mice.  Serum total  cholesterol  was determined by the method of  Sperry  and Webb (2), 
and serum lipide  phosphorus by the procedure of Fiske and SubbaRow (3).  The figures  for 
hpidc  phosphorus  were  converted to  milligrams  of  phospholipide  per i00  cc.  by multiplying  by 
a factor  of 25. Numerous trials  have shown that triton  does not interfere  with the colori- 
metric procedures used for the determination of cholesterol  or lipide  phosphorus. 
Total  body cholesterol  was measured by a modification  of  the method of  Schoenheimer and 
Breusch (4).  The mice were sacrificed  by cxsanguination or by ether anesthesia,  and the 
carcasses  were completely digested  in 200 cc. of  a solution  containing  cquai parts  of absolute 
alcohol  and acetone,  and 15 gin.  of sodium hydroxide. The digestion  mixture  was refluxed  for 
2 hours,  neutralized  with  hydrochloric  acid,  and made up to 500 cc.  with the alcohol-acetone 
solution.  Aliquots of  this  mixture  were analyzed for  total  cholesterol  in duplicate  or triplicate 
by the method of Sperry and Webb (2).  In the case of  animals exsanguinated prior  to death, 
the cholesterol  content of  the serum was added to that of  the carcass  in  computing the total 
body cholesterol.  No correction  was made for the cholesterol  content of the red blood cells 
removed. In a number of trials  in control animals the addition of triton  to the digestion 
mixture did not affect  the determination of total  body cholesterol. 
Increased Serum Clmlesterol and Phospholipides  in Mice 
Given Injections o/Triton Intravenously 
An experiment was  first done  to  learn  the normal  range  of  the  serum  cho- 
lesterol and phospholipides  in mice, and to determine whether the intravenous 
injection of  triton  would  produce  hyperlipemia  in  these  animals  comparable 
to that observed in rabbits. 
Three groups of mice were used in this experiment. Group 1 consisted of thirty-six normal 
uninjected control mice; the blood serum obtained from three to five animals was pooled for 
the lipide determinations. Group 2 consisted of fourteen mice that were each given a  single 
intravenous injection of 0.2 cc. of 12.5 per cent triton. Blood for lipide determinations was 
obtained by bleeding four animals 15 minutes after injection, five after 24 hours, and five 
others after 48 hours. Group 3 consisted of eleven mice each of which received three intrave- 
nous injections of 0.2 cc. of 12.5 per cent triton, spaced at 2 to 3 day intervals. These animals 
were bled 2 days after the last injection, and lipide determinations were made on the indi- 
vidual samples. 
Manufactured by Rohm and Haas, Inc., Philadelphia. 
' It is of interest to note that with batches of triton obtained from the manufacturer prior 
to  1953 there  regularly occurred a  generalized convulsion following intravenous injection, 
similar to that  previously described in rabbits  (1).  Batches obtained after  1953, however, 
did not produce convulsions. There were no differences in the character of the hyperlipemia 
elicited by the various lots of triton employed. TABLE  I 
Serum Cholesterol and Phospholiplde Levels of Mice Given Triton Intravenously 
Experimental group 
1.  Control mice, not 
injected 
Mouse No.  Time after 
injection  Cholesterol 
Pool 1" 
mg./lOO ¢¢. 
94 
96 
102 
105 
108 
118 
138 
Phosphollpide 
rag.~100 ¢¢. 
195 
220 
223 
213 
215 
225 
297 
Mean.  109  229 
15 rain.  106  238 
2 
3 
4 
2.  Mice  given  a 
single injection of 
0.2 cc. of 12.5 per 
cent triton intra- 
venously 
664 
705 
629 
595 
624 
1480 
1395 
777 
1160 
1330 
24 hrs. 
Mean.  643  1028 
48hrs.  660 
552 
1085 
924 
558 
10 
11 
12 
13 
14 
843 
525 
1610 
1500 
727 
Mean.  756  1039 
48 hrs.  1070 
1145 
1455 
1575 
1645 
1743 
1770 
1845 
1950 
2100 
2455 
3.  Mice  given 3  in- 
jectionsofO.2 cc. 
of  12.5  per  cent 
triton  intraven- 
ously 
915 
875 
1390 
1825 
1740 
1840 
1715 
2025 
2420 
1800 
2000 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
Mean.  1623  1689 
* Serum obtained from three to five normal mice was pooled in each case. 
Serum of these four mice pooled for lipide determinations. 
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The serum cholesterol and phospholipide levels of these animals are  given in Table L 
Normal mice were found to have a mean serum cholesterol level of 109 rag. per 100 cc., the 
values for the various pools of normal serum ranging from 94 to 138. The mean phospholipide 
level was 229 mg. per 100 cc., with a range of 195 to 297, It is noteworthy that normal mouse 
serum regularly contained more phospholipide than cholesterol, the same being true of the 
sera of rabbits, dogs, and human beings (5). 
The animals in Group 2, which had been given a single intravenous injection of triton, 
showed no change in serum cholesterol and phospholipide content at 15 minutes. There was a 
striking increase, however, in the serum levels of both lipides after 24 and 48 hours, the choles- 
terol levels ranging from 552 to 1085 mg. per cent, and the phospholipide levels from 525 to 
1610 mg. per cent. In other studies it was found that the elevated serum and lipides returned 
to the normal range within 5 to 10 days following  injection. All the sera with elevated lipide 
levels were milky. The lipemia found in mice given triton was similar to that reported pre- 
viously in rabbits (1), though the lipide levels attained in the case of the mice were somewhat 
higher, probably because the amount of triton given the mice was considerably greater, on a 
comparative weight basis, than that given the rabbits. 
The cholesterol levels of the animals given three injections of triton varied from 1070 to 
2455 rag. per 100 cc., with a mean of 1523, while the phospholipides ranged from 875 to 2420 
rag. per cent, with a mean of 1689 (see Table I). Again, all sera were strikingly lactescent and 
had a creamy consistency. The increase in serum phospholipides generally paralled that of 
the cholesterol, though in several instances the cholesterol level was appreciably higher than 
the corresponding phosphoUpide level. The fact that the serum in all cases was milky at the 
height of Upemia suggests that, as in the case of rabbits given triton, there was also a notable 
increase in serum neutral fat (1, 6), though this group of lipides was not measured in these 
experiments. 
It  was  clear  from  this  experiment that  a  marked  hyperlipemia could  be 
induced readily in mice by the  intravenous injection of  triton, and further, 
that  the  hyperlipemia was  similar both  qualitatively and quantitatively to 
that seen in triton-injected rabbits. It appeared feasible, therefore, to employ 
the  mouse  as  an experimental animal in studies of  the  pathogenesis of  the 
hyperlipemia induced by surface-active agents. 
Increased  Total  Body  Cholesterol in  Mice  Given Triton  Intravenously 
In exploring the  possible mechanisms that  might account for  the  hyper- 
lipemia caused by injected surface-active agents,  two  alternatives were  con- 
sidered:  (a)  that  the  hyperlipemia could be  due  to  mobilization of  existing 
lipides from the tissues and body stores into the blood stream, in which case 
the  total amount of  the involved lipides in the animal's body would be ex- 
pected to remain essentially unchanged; and (b)  that the hyperlipemia could 
be due to alterations in the synthesis, degradation, or excretion of lipides, in 
which case an absolute increase in the total amount of the affected lipides in 
the animal's body should take place. As a first test of these alternatives, total 
body cholesterol was determined in a  group of normal control mice and in a 
group of comparable mice given triton intravenously. Cholesterol was chosen 
as  the  lipide  to  be  studied because  it was  not appreciably affected  by the R. L. HIRSCH AND  A. KELLNER 
drastic procedure  necessary to digest the carcass,  and also because it could be 
precipitated  readily  and  quantitatively  from  the  digestion  mixture  as  the 
insoluble digitonide. 
The total amount of cholesterol in the bodies of seventeen uninjected normal control mice 
ranged from 38.6 to 82.2 rag. with a mean of 59.7 rag.  (Table II). The per cent of the body 
weight composed of cholesterol varied within comparatively narrow limits--from 0.26 to 0.30 
per cent, with a mean of 0.28 per cent. These figures agree closely with those of Schoenheimer 
TABLE  II 
Total Body Cholesterol of Normal Mice 
Cholesterol as per cent  Mouse No.  Weight  Total body cholesterol  of body weight 
26 
27* 
28 
29* 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41" 
42* 
Mean..  , 
ggt). 
14.2 
15.7 
16.1 
17.5 
18.6 
20.2 
20.6 
21.4 
21.6 
22.0 
23.4 
24.1 
24.1 
24.9 
25.0 
28.9 
29.7 
mg. 
38.6 
45.6 
47.5 
52.5 
50.5 
55.0 
54.5 
57.7 
57.5 
61.2 
64.3 
64.3 
69.9 
69.4 
64.9 
78.9 
82.2 
59.7 
0.27 
0.29 
0.29 
0.30 
0.27 
0.27 
0.26 
0.27 
0.27 
0.28 
0.27 
0.27 
0.29 
0.28 
0.26 
0.27 
0.28 
0.28 
* 0.6 cc. of 12.5 per cent triton was added to the extraction  mixture in these cases as a 
further control of the effect of triton on the determination of the total body cholesterol con- 
tent. 
and Breusch who found the total body cholesterol of male mice to range between 0.28 and 
0.31 per cent of body weight (4). 
The total body cholesterol of 73 animals sacrificed at intervals following a single intravenous 
injection of triton increased in parallel with the serum cholesterol levels, as Table III shows; 
there was no change in 15 minutes, a sharp rise above the normal occurred in 24 hours, and a 
peak value was attained at 48 hours, with a  gradual return to normal by the 7th day. The 
total body cholesterol content was found to be increased about 33 per cent above the normal 
in these animals at the height of lipemia. The mean values for total body cholesterol at varying 
intervals of time following injection of triton are shown graphically in Fig.  1. 
The figures for total body cholesterol of eleven mice receiving multiple injections of triton 
are given in Table IV. These animals were given 3 intravenous injections of 0.2 cc.  of 12.5 6  PATHOGENESIS  OF  HYPERLIPEMIA.  I 
TABLE  III 
Total Body Cholesterol of Mice Given a Single Injection of Triton Intravenously* 
Time after  Weight$  Total body  Cholesterol  as per 
Mouse No.  injection  cholesterol  cent of body weight 
43 
44 
45 
46 
47 
48 
49 
50 
gm. 
24.1 
21.0 
23.5 
21.3 
26.9 
26.0 
28.4 
28.9 
rag. 
69 
55 
68 
64 
79 
74 
75 
80 
0.286 
0.262 
0.29 
0.30 
0.293 
0.285 
0.264 
0.278 
Mean ...........................................................  O. 282 
15 min.  24.7 
23.0 
24.9 
22.4 
20.2 
24.0 
20.4 
23.2 
20.0 
21.2 
24.3 
25.8 
65 
62 
62 
58 
57 
70 
61 
67 
56 
60 
71 
75 
51 
52 
53 
54 
55 
56 
57 
58 
59 
6O 
61 
62 
0.26 
0.27 
0.25 
0.26 
0.282 
0.291 
0.298 
0.288 
0.28 
0.283 
0.292 
0.29 
Mean ...........................................................  0.278 
24hrs.  68 
90 
61 
63 
57 
65 
63 
79 
68 
77 
67 
71 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
21.4 
25.4 
19.0 
20.0 
17.0 
21.2 
20.8 
21.9 
20.6 
20.7 
18.6 
20.4 
0.32 
0.354 
0.322 
0.312 
0.324 
0.306 
0.303 
0.306 
0.33 
0.37 
0.36 
0.34 
Mean ...........................................................  0.329 R.  L.  HIRSCH  AND  A.  KELLNER 
TABLE  III---Conlinued 
Time after  Total body  Cholesterol  as per 
Mouse No.  injection  Weight~:  cholesterol  cent of body weight 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
2 days 
gm, 
23.0 
19.6 
20.3 
21.2 
25.8 
20.2 
20.9 
21.2 
21.1 
22.0 
21.9 
22.8 
rag. 
91 
79 
83 
87 
89 
82 
77 
79 
73 
78 
80 
79 
0.40 
0.40 
0.43 
0.40 
0.346 
0.405 
0.368 
0.372 
0.345 
0.354 
0.364 
0.346 
Mean ...........................................................  0.375 
3 days  19.8 
28.7 
22.1 
21.6 
20.5 
24.4 
21.7 
21.8 
18.2 
21.1 
19.5 
73 
92 
79 
79 
75 
85 
74 
81 
73 
73 
72 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
97 
0.366 
0.32 
O. 348 
0.365 
O. 366 
0.348 
0.341 
0.374 
0.40 
0.34 
0.37 
Mean ..........................................................  O. 358 
4 days  83 
81 
79 
85 
65 
79 
80 
78 
98 
99 
100 
101 
102 
103 
104 
105 
23.7 
23.3 
22.6 
21.2 
22.5 
23.1 
23.2 
20.9 
0.35 
0.347 
0.35 
0.40 
0.32 
0.342 
0.344 
0.373 
Mean ...........................................................  0.353 
106  6 days  22.2  68  0.30 
107  21.2  63  0.29 
Mean ...........................................................  0.295 PATHOGENESIS  OF  HYPERLIPEMIA.  I 
TABLE  III--Condude~ 
Time after  Weight;~  Torsi body  Cholesterol as pe.r 
Mouse No.  injection  cholesterol  cent of body welght 
108 
109 
110 
111 
112 
113 
114 
115 
7 days  27.0 
25.1 
26.4 
24.4 
21.8 
25.2 
23.9 
25.6 
mZ. 
70 
71 
71 
65 
60 
71 
65 
67 
0.26 
0.294 
0.269 
0.266 
0.275 
0.282 
0.272 
0.262 
Mean ...........................................................  0.272 
* Each mouse was given a single injection of 0.2 cc. of 12.5 per cent triton intravenously. 
Animals weighed at the time of sacrifice. 
CHOLESTEROL 
AS 
PER CENT 
OF 
BODY 
WEIGHT 
0.38 
0.36 
0,34 
0.32 
0.30 
0.28 
0.26  :'- 
0.24 
15 
min. 
............  ....................... 
I  1  I  I  I  I 
2  3  4  5  6  7 
TIME  AFTER  INJECTION  (DAYS) 
FIG.  1. Total body cholesterol d  mice given a single intravenous injection of triton WR 
1339. 
Each point represents the mean value for the total body cholesterol of 2 to 12 mice. 11.  L.  HIRSCH  AND  A.  KELLIVER 
per cent triton at 2 to 3 day intervals, and were killed by exsanguination 2 days following the 
last injection. The total amount of cholesterol in these animals ranged from 72.9 to 104.5 mg., 
with a mean of 90.0 nag., and the cholesterol as per cent of the body weight varied from 0.38 
to 0.54, with a mean of 0.47 per cent. This represents an average increase in total body choles- 
terol of 58 per cent above the normal. 
The  findings  of  these  experiments  indicate  that  there  was  a  substantial 
increase  in  the  total  body  cholesterol  of mice given  single  or repeated  intra- 
TABLE IV 
UIean. 
Total Body Cholesterol of Mice Given Rt ,eared  Injections of Triton Intravenously* 
Cholesterol  as per cent  Mouse No.~  Weight§  Total body cholesterol  of body weight 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
grtl° 
23.9 
20.4 
23.4 
16.3 
20.3 
19.0 
18.9 
18.9 
21.2 
20.3 
19.3 
mg. 
90.9 
81.6 
103.0 
72.9 
91.9 
75.5 
82.9 
95.9 
96.7 
94.3 
104.5 
90.0 
0.38 
0.40 
0.44 
0.45 
0.45 
0.40 
0.44 
0.51 
0.46 
0.46 
0.54 
0.47 
* Each mouse was given three injections of 0.2 cc. of 12.5 per cent triton intravenously 
at 2 to 3 day intervals. The animals were sacrificed 48 hours after the last injection. 
The animals in th/s table  are the same as  those with  the corresponding numbers  in 
Table I. 
§ Animals weighed at the time of sacrifice. 
venous  injections  of  triton,  and  that,  in  general,  this  increase  paralleled  the 
degree of lipemia. 
Effect  of Subcutaneous  Injection  of  Triton  on  the  Serum  Cholesterol 
and Total Body Cholesterol of Mice 
To  broaden  the  findings,  an  experiment  was  done  to  determine  whether 
the  surface-active  agent  had  to  be introduced  directly into  the  blood  stream 
in order  to be effective or whether  administration  by other routes  would also 
result in hyperlipemia. 
Eleven mice were given three subcutaneous injections of 0.2 cc. of 12.5 per cent triton at 
intervals of 2 to 3 days. The animals were bled and killed 2 days following the last injection. 
The data in Table V  show that the serum cholesterol levels ranged from 251  to 489  mg. per 10  PATHOGENESIS  OF  HYPERLIPEMIA.  I 
108 cc. and the total body cholesterol from 81.7 to 113.9  rag. The cholesterol as per cent of 
body weight varied from 0.31 to 0.43, with a mean of 0.38 per cent. The levels of both serum 
cholesterol and total body cholesterol were distinctly higher than those of the normal control 
animals (Tables I and II), though they were considerably lower than those attained by mice 
given triton intravenously (Tables I  and IV). 
It was concluded from this experiment that triton injected subcutaneously 
brought about a  significant increase in the serum and total body cholesterol 
TABLE  V 
Serum Cholesterol and Total Body Cholesterol of Mice Given Triton Subcutaneously* 
Mouse No.  Weight  Serum  cholesterol  Total  body  Cholesterol as per  cholesterol  cent of body weight 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
23.3 
24.3 
24.3 
24.7 
26.0 
26.2 
26.3 
28.1 
29.7 
30.2 
30.4 
mg./lO0 co. 
489 
334 
412 
351 
441 
251 
381 
268 
345 
322 
298 
rag. 
85.5 
81.7 
102.1 
96.8 
108.2 
89.3 
113.9 
98.3 
113.7 
100.6 
93.5 
0.40 
0.34 
0.42 
0.39 
0.42 
0.35 
0.43 
0.35 
0.38 
0.33 
0.31 
Heart..  .  288  0.38 
* Each mouse was given 3 injections of 0.2 cc. of 12.5 per cent triton subcutaneously at 2 to 
3 day intervals. The animals were weighed and sacrificed by exsanguination 48 hours after 
the last injection. 
of mice, though its effectiveness in this regard was notably less than that of 
the same agent administered intravenously. 
DISCUSSION 
In these experiments mice given parenteral injections of the surface-active 
agent triton WR 1339 developed not only a marked increase in serum lipides 
but also a  significant increase in total body cholesterol. Dietary factors had 
little or nothing to do with these changes, since the animals were fed a  low 
fat,  cholesterol-free diet.  The  fact  that  the  total  body  cholesterol was  in- 
creased under  these  circumstances  makes  it  plain  that  the  hypercholester- 
olemia must have resulted from some induced alteration in the metabolism of 
cholesterol rather than from transfer of the lipide from the  tissues into the 
blood stream. Such an increase could have come about either from increased 
synthesis  or  decreased  degradation  or  excretion  of  cholesterol,  or  from  a 
combination of such alterations. R. L. HIRSCH AND  A. KELLNER  11 
The liver  is known to be  the major source of endogenous  cholesterol  (7). 
Furthermore, the liver can produce  greatly increased quantities of cholesterol 
following the injection of triton,  as  is  shown  in  the studies of Frantz and 
Hinkelman who  noted that liver  slices from rats  given  triton incorporated 
radioactive acetate into cholesterol at a  rate three times that of normal (8). 
Yet, extrahepatic synthesis of cholesterol may also occur (9), and it is mani- 
festly possible  that other tissues,  which  have  the ability to synthesize cho- 
lesterol  but under normal conditions  contribute relatively little to  the cho- 
lesterol  pool,  might,  under  the  influence  of  triton,  greatly accelerate  their 
rates of synthesis. Moreover,  the liver  provides  the major pathway for the 
excretion of cholesterol  (10), and there is evidence that  this function, too, is 
altered in  animals given  surface-active  agents; rabbits  injected with  triton 
and given C-14 labelled cholesterol by vein excreted  less radioactive material 
in their feces than did control animals (11). Taken together, the observations 
suggest that increased synthesis and decreased excretion may both participate 
in the process whereby surface-active  agents induce hyperlipemia,  though the 
findings do not show precisely how these metabolic alterations are effected. 
From simple  calculations  that can be  made from data  contained in  this 
paper,  it seems probable  that the bulk of the increment in cholesterol in the 
triton-injected  animals  was  contained  within  the  circulating  body  fluids. 
Using  the mean figures from Tables  II and  IV,  a  mouse  weighing  20  gm. 
given three injections of triton intravenously and sacrificed 48 hours after the 
last injection would have 56 mg. of cholesterol in its body at the outset and 
94 mg. at the end of the experiment,  an increase of 38 mg.  The plasma cho- 
lesterol  concentration would rise at the same time from 109  to 1623 nag. per 
100 cc. (Table  I). Since plasma comprises slightly more than 6 per cent of a 
mouse's body weight (12), this mouse  would  have  1.2  cc.  of plasma which 
would contain 1.3 mg. of cholesterol at the start of the experiment and 19.5 
mg. at the end, an increase of 18.2 mg. Thus, almost half of the  total incre- 
ment of cholesterol in the animal's body can be accounted for in the plasma 
alone.  The extracellular  tissue  fluid and the lymph together comprise  some 
15 per cent of the body weight of normal mice (13). It is reasonable to assume 
this is also true of mice that have received triton since no changes were noted 
in their body weight and no gross changes have been observed in the distribu- 
tion of their body fluids. The extracellular  tissue fluid and lymph have been 
shown  to  contain cholesterol  and other lipides  in a  concentration equal  to 
about one-third that of the plasma in both normal and triton-treated animals 
(14); hence, an additional 15  nag. of cholesterol probably is present in these 
fluid compartments of  the  triton-injected mouse.  If  these  assumptions  are 
correct,  then  the major portion of the increment in  total body cholesterol 
that follows the administration of triton is contained within the plasma,  the 
lymph, and  the  extracellular  tissue  fluid.  The  finding  would  be  consistent 
with the hypothesis that triton  acts directly on the lipoprotein molecules and 12  PATHOGENESIS  OF  HYPERLIPEMIA.  I 
holds them in the circulating body fluids. A similar hypothesis to explain the 
action of triton has been advanced by Friedman and Byers (15),  and will be 
discussed further in the accompanying paper (16). 
SUMMARY 
Mice rendered hyperlipemic by means of intravenous or subcutaneous in- 
jections of triton WR 1339 were found to have an increase in the total amount 
of  cholesterol in  their  bodies.  This  observation  indicates  that  the  injected 
surface-active agent affects the  metabolism of cholesterol and brings about 
hyperlipemia by augmenting the synthesis of lipides, or by interfering with 
their degradation or excretion, or by some combination of these factors. The 
implications of the findings for the pathogenesis of the hyperlipemia induced 
by triton are discussed further in the accompanying paper (16). 
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